Declaration – Malignant Neoplasm of the Breast

Overview

The Repatriation Medical Authority, established under the Veterans' Entitlements Act 1986, has issued a declaration regarding the Statements of Principles concerning malignant neoplasm of the breast (Nos. 96 and 97 of 2014, as amended). This declaration, published in the Commonwealth of Australia Gazette on 22 October 2021, follows a focused review prompted by an investigation into whether the use of combined hormonal contraceptives, beyond combined oral contraceptive pills, should be considered a factor in the development of malignant neoplasm of the breast. The Authority has concluded that, based on the available medical-scientific evidence, there is not sufficient basis to propose amendments to the current Statements of Principles to include factors relating to taking combined hormonal contraceptives, other than a combined oral contraceptive pill. This decision is aimed at ensuring that the statements are supported by sound evidence, thereby maintaining the integrity and accuracy of the entitlements process for veterans.

Scope and Application

The Veterans' Entitlements Act 1986 applies to Australian veterans and their dependants who are seeking benefits related to war service. Specifically, the Act governs the entitlements of veterans, including health care, pensions, and rehabilitation services. The Repatriation Medical Authority, which is responsible for determining medical-scientific evidence related to veterans' claims, exercises its powers under the Act. In this context, the Authority's declaration pertains to the Statements of Principles concerning malignant neoplasm of the breast, which were established to outline the medical conditions that can be linked to military service for the purposes of entitlement claims. The Authority's decision not to amend the Statements of Principles concerning malignant neoplasm of the breast to include factors relating to taking combined hormonal contraceptives, other than a combined oral contraceptive pill, is based on the available sound medical-scientific evidence. This decision applies nationally, as the Repatriation Medical Authority operates under the Commonwealth of Australia, and its declarations are binding across the entire country. The Authority's actions are outlined in the Gazette, ensuring transparency and adherence to the legislative framework.

Key Provisions

The Veterans' Entitlements Act 1986 (the Act) has been subject to a review concerning its Statements of Principles regarding malignant neoplasm of the breast (Nos. 96 and 97 of 2014, as amended). Under subsection 196B(9) of the Act, the Repatriation Medical Authority (the Authority) revoked its earlier declaration and issued a new one, stating that it does not propose to amend the Statements of Principles concerning malignant neoplasm of the breast. This change follows an investigation into the potential factors related to combined hormonal contraceptives, as announced in the Commonwealth of Australia Gazette on 9 March 2021. The Authority’s decision is based on the sound medical-scientific evidence available, including new evidence, which does not support the hypothesis that taking combined hormonal contraceptives, other than a combined oral contraceptive pill, is a factor in malignant neoplasm of the breast. As a result, the evidence does not justify amending the existing Statements of Principles (Nos. 96 and 97 of 2014, as amended) to include broader factors related to combined hormonal contraceptives. The Authority, under the Act, has a responsibility to ensure that the Statements of Principles accurately reflect the current medical-scientific understanding of factors contributing to malignant neoplasm of the breast. This includes reviewing new evidence and deciding whether it warrants an amendment to the existing Statements of Principles. Additionally, the Authority must communicate its decisions transparently, ensuring that stakeholders are informed of any changes or reaffirmations. Breach of the obligations imposed by the Act could lead to legal consequences for the Authority or other involved parties. While the Act does not explicitly detail the specific penalties for non-compliance, general provisions within the Act may provide for civil or criminal penalties. These could include fines or other sanctions, depending on the nature and severity of the breach. The Authority is tasked with ensuring that its decisions are well-founded on medical-scientific evidence, and any failure to adhere to this requirement could result in significant repercussions.